Evidence mapPaperPMID 40697377Full record

ArticleFrontiers in oncology2025

Association between neutrophil-lymphocyte ratio and female breast cancer: an observational study from NHANES 2001-2018 with external validation.

Juan Xiong, Deju Zhang, Jing Wu, Peili Yang, Donghai Shi, Xiaolan Zhou, Ying Yuan, Chuntao Quan, Ni Xie

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Juan Xiong *BioBank, Shenzhen Second People's Hospital, Heng Yang Medical School, University of South China, Hengyang, Hunan, China.
Deju Zhang *BioBank, Shenzhen Second People's Hospital, Heng Yang Medical School, University of South China, Hengyang, Hunan, China.
Jing Wu *Department of Infectious Diseases, Peking University Shenzhen Hospital, Shenzhen, China.
Peili YangBioBank, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen, China.
Donghai ShiBioBank, Shenzhen Second People's Hospital, Heng Yang Medical School, University of South China, Hengyang, Hunan, China.
Xiaolan ZhouBioBank, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen, China.
Ying YuanBioBank, Shenzhen Second People's Hospital, Heng Yang Medical School, University of South China, Hengyang, Hunan, China.
Chuntao QuanBioBank, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen, China.
Ni XieBioBank, Shenzhen Second People's Hospital, Heng Yang Medical School, University of South China, Hengyang, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In the 21st century, breast cancer is the most frequent malignant tumor threatening women's health. Previous research has confirmed that inflammatory response processes play key roles in tumor occurrence, development, and metastasis. The neutrophil-to-lymphocyte ratio (NLR), an emerging disease biomarker, has become a focus of cancer research. However, analysis of the relationship between NLR and breast cancer remains scarce. Therefore, our study explored NLR levels in relation to female breast cancer (FBC) prevalence. Methods: We analyzed data from 15,313 adult females aged 20 and above, using the 2001 to 2018 National Health and Nutrition Examination Survey (NHANES). We explored the association between NLR and FBC prevalence using multiple statistical approaches, including descriptive analysis, multivariate logistic regression, and subgroup analyses. We applied Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC) to measure model performance. Additionally, smooth curve fitting examined the potential non-linear relationship. To validate our findings, an independent external validation dataset comprising 250 participants (50 breast cancer cases and 200 controls) from Shenzhen Second People's Hospital was utilized, and correlation between NLR values and breast cancer prevalence was calculated. Results: NLR was positively associated with FBC prevalence among US women. In the fully adjusted model, each unit NLR elevation increased FBC prevalence odds by 14% [OR = 1.14 (95% CI: 1.08, 1.22)]. Participants in the highest quartile of NLR had 67% higher FBC prevalence compared to those in the lowest quartile [OR = 1.67 (95% CI: 1.24, 2.24)], with statistical significance across three models at Conclusions: In the U.S. adult female population, NLR levels were positively correlated with breast cancer prevalence. External validation in Chinese clinical participants supported the generalizability of these findings across different populations.

Indexed as

AIC/BICcross-sectional studyfemale breast cancerneutrophil-lymphocyte ratioNHANES

Identifiers

PMID40697377
PMCPMC12280361

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.